tirzepatide consent form GLP-1 Weight Loss Forms and SOPs Behind every signed consent form
Description
That's why we create personalized treatment plans tailored to your specific needs and objectives
Tapering and Off-Cycle When concluding the research protocol, gradual tapering of retatrutide (reducing by 0.5 mg/week every 2 weeks) is preferred over abrupt cessation to avoid rebound appetite dysregulation
Gradual dose reduction may be appropriate if maintaining stable benefits on lower amounts
Conclusion As of 2025, no FDA-approved generic version of Zepbound is available in the United States
